PathVysion® HER-2 DNA Probe Kit enables completely objective assessment of the HER-2/NEU gene by enabling the reader to simply count HER-2 gene copy numbers in interphase nuclei of malignant cells. The FDA-approved assay provides standardization, sensitivity and simplicity of analysis. UroVysionTM Bladder Cancer Kit (UroVysion Kit) enables the detection of a specific set of chromosome abnormalities that is indicative of a recurrence of bladder cancer. The assay is the industry's first genomic DNA-probe test for monitoring recurrence of bladder cancer to be cleared for IVD use by the FDA. AneuVysion® Assay enables detection of trisomy 13, 18, 21 and sex chromosome aneusomies. The FDA cleared assay offers rapid, accurate and reliable results in 24 to 48 hours. GenoSensorTM System, utilizing CGH array technology, offers a complete approach to genomic research including arrays, instrumentation, software and reagents for simultaneous assessment of multiple gene targets. CEP® Chromosome Enumeration DNA Probesproduce distinctive fluorescent signals or "dots" and allow for rapid counting to determine if there are too few or too many chromosomes within each cell. Since abnormal chromosome numbers are correlated with many cancers, this tool has significant value. LSI® Locus Specific Identifier DNA Probes hybridize to specific locations on individual chromosomes and identify specific sequences of DNA that are gene or locus specific. This tool provides outstanding potential for use in tests in cancer, prenatal disease and genetic disease predisposition.
TelVysionTM Telomere DNA Probes produce distinct fluorescent signals to detect chromosome-specific subtelomeric regions of human chromosomes. The products can be used to identify deletions and balanced or unbalanced translocations of telomeric regions that have been associated with mental retardation and other diseases.
SpectraVysionTM Assay consists of an optimized formulation of directly labeled WCP® probes mixed in combination to provide distinct identification of the 24 human chromosomes. 24 color M-FISH is used for the identification of chromosome anomalies that are not identifiable using traditional cytogenetic banding methods. CGH Reagents include a complete line of components for performing Comparative Genomic Hybridization, a powerful research tool for determining previously unidentified gene amplifications and deletions in genetic diseases and cancers. VP 2000 Processor is the industry's first consolidated workstation to automate deparaffinization, FISH specimen pretreatment and routine slide staining, thus dramatically reducing laboratory labor and costs. A single system handles 50 slides per run and is validated for use with Vysis® FISH pretreatment protocols including solid tumor and cytological specimens such as amniocytes and bladder tumor cells. HYBriteTM Hybridization System provides for rapid, easy, safe FISH procedures through a hands-free, denaturation/hybridization system. The instrument eliminates the need to prepare and dispose of hazardous solutions such as formamide and ethanol while cutting start-to-finish hands-on time from about 40 minutes to just 15 minutes. HYBrite is optimized for use with Vysis' CEP, LSI and WCP probes.
